Literature DB >> 18411303

Phosphorylation of fibroblast growth factor (FGF) receptor 1 at Ser777 by p38 mitogen-activated protein kinase regulates translocation of exogenous FGF1 to the cytosol and nucleus.

Vigdis Sørensen1, Yan Zhen, Malgorzata Zakrzewska, Ellen Margrethe Haugsten, Sébastien Wälchli, Trine Nilsen, Sjur Olsnes, Antoni Wiedlocha.   

Abstract

Exogenous fibroblast growth factor 1 (FGF1) signals through activation of transmembrane FGF receptors (FGFRs) but may also regulate cellular processes after translocation to the cytosol and nucleus of target cells. Translocation of FGF1 occurs across the limiting membrane of intracellular vesicles and is a regulated process that depends on the C-terminal tail of the FGFR. Here, we report that translocation of FGF1 requires activity of the alpha isoform of p38 mitogen-activated protein kinase (MAPK). FGF1 translocation was inhibited after chemical inhibition of p38 MAPK or after small interfering RNA knockdown of p38alpha. Translocation was increased after stimulation of p38 MAPK with anisomycin, mannitol, or H2O2. The activity level of p38 MAPK was not found to affect endocytosis or intracellular sorting of FGF1/FGFR1. Instead, we found that p38 MAPK regulates FGF1 translocation by phosphorylation of FGFR1 at Ser777. The FGFR1 mutation S777A abolished FGF1 translocation, while phospho-mimetic mutations of Ser777 to Asp or Glu allowed translocation to take place and bypassed the requirement for active p38 MAPK. Ser777 in FGFR1 was directly phosphorylated by p38alpha in a cell-free system. These data demonstrate a crucial role for p38alpha MAPK in the regulated translocation of exogenous FGF1 into the cytosol/nucleus, and they reveal a specific role for p38alpha MAPK-mediated serine phosphorylation of FGFR1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18411303      PMCID: PMC2423127          DOI: 10.1128/MCB.02117-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

1.  TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1beta ), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1.

Authors:  Baoxue Ge; Xinsheng Xiong; Qing Jing; Jennifer L Mosley; Angela Filose; Dafang Bian; Shuang Huang; Jiahuai Han
Journal:  J Biol Chem       Date:  2002-11-11       Impact factor: 5.157

Review 2.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

3.  Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors.

Authors:  Ellen Margrethe Haugsten; Vigdis Sørensen; Andreas Brech; Sjur Olsnes; Jørgen Wesche
Journal:  J Cell Sci       Date:  2005-08-09       Impact factor: 5.285

4.  Two nuclear localization signals required for transport from the cytosol to the nucleus of externally added FGF-1 translocated into cells.

Authors:  Jørgen Wesche; Jedrzej Małecki; Antoni Wiedłocha; Maryam Ehsani; Ewa Marcinkowska; Trine Nilsen; Sjur Olsnes
Journal:  Biochemistry       Date:  2005-04-26       Impact factor: 3.162

5.  Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1.

Authors:  R Zinck; M A Cahill; M Kracht; C Sachsenmaier; R A Hipskind; A Nordheim
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

6.  Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor.

Authors:  S E Winograd-Katz; A Levitzki
Journal:  Oncogene       Date:  2006-06-19       Impact factor: 9.867

7.  p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation.

Authors:  P Maher
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

8.  Direct regulation of rRNA transcription by fibroblast growth factor 2.

Authors:  Zhi Sheng; Yanping Liang; Chih-Yin Lin; Lucio Comai; William J Chirico
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

9.  Phosphorylation-regulated nucleocytoplasmic trafficking of internalized fibroblast growth factor-1.

Authors:  Antoni Wiedłocha; Trine Nilsen; Jørgen Wesche; Vigdis Sørensen; Jedrzej Małecki; Ewa Marcinkowska; Sjur Olsnes
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

10.  Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun.

Authors:  E Cano; C A Hazzalin; L C Mahadevan
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

View more
  26 in total

1.  Reactive oxygen species-mediated p38 MAPK regulates carbon nanotube-induced fibrogenic and angiogenic responses.

Authors:  Neelam Azad; Anand Krishnan V Iyer; Liying Wang; Yuxin Liu; Yongju Lu; Yon Rojanasakul
Journal:  Nanotoxicology       Date:  2012-01-20       Impact factor: 5.913

2.  Internalization of biotinylated compounds into cancer cells is promoted by a molecular Trojan horse based upon core streptavidin and clostridial C2 toxin.

Authors:  Jörg Fahrer; Joschua Funk; Maren Lillich; Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-07       Impact factor: 3.000

3.  Rapid actions of plasma membrane estrogen receptors regulate motility of mouse embryonic stem cells through a profilin-1/cofilin-1-directed kinase signaling pathway.

Authors:  Seung Pil Yun; Jung Min Ryu; Mi Ok Kim; Jae Hong Park; Ho Jae Han
Journal:  Mol Endocrinol       Date:  2012-06-25

Review 4.  Physical-chemical principles underlying RTK activation, and their implications for human disease.

Authors:  Lijuan He; Kalina Hristova
Journal:  Biochim Biophys Acta       Date:  2011-08-05

5.  The effects of p38 gene silencing on breast cancer cells.

Authors:  Fulya Doğaner; Didem Turgut Coşan; Hasan Veysi Güneş; Irfan Değirmenci; Cengiz Bal
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

Review 6.  MAPK and PI3K signaling: At the crossroads of neural crest development.

Authors:  Colin J Dinsmore; Philippe Soriano
Journal:  Dev Biol       Date:  2018-02-14       Impact factor: 3.582

7.  Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.

Authors:  Ibrahim Qaddoumi; Wilda Orisme; Ji Wen; Teresa Santiago; Kirti Gupta; James D Dalton; Bo Tang; Kelly Haupfear; Chandanamali Punchihewa; John Easton; Heather Mulder; Kristy Boggs; Ying Shao; Michael Rusch; Jared Becksfort; Pankaj Gupta; Shuoguo Wang; Ryan P Lee; Daniel Brat; V Peter Collins; Sonika Dahiya; David George; William Konomos; Kathreena M Kurian; Kathryn McFadden; Luciano Neder Serafini; Hilary Nickols; Arie Perry; Sheila Shurtleff; Amar Gajjar; Fredrick A Boop; Paul D Klimo; Elaine R Mardis; Richard K Wilson; Suzanne J Baker; Jinghui Zhang; Gang Wu; James R Downing; Ruth G Tatevossian; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-01-25       Impact factor: 17.088

8.  The protein phosphatase 2A regulatory subunits B'beta and B'delta mediate sustained TrkA neurotrophin receptor autophosphorylation and neuronal differentiation.

Authors:  Michael J Van Kanegan; Stefan Strack
Journal:  Mol Cell Biol       Date:  2008-11-24       Impact factor: 4.272

9.  Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.

Authors:  Malgorzata Zakrzewska; Antoni Wiedlocha; Anna Szlachcic; Daniel Krowarsch; Jacek Otlewski; Sjur Olsnes
Journal:  J Biol Chem       Date:  2009-07-02       Impact factor: 5.157

10.  p38-MAPK-mediated translation regulation during early blastocyst development is required for primitive endoderm differentiation in mice.

Authors:  Pablo Bora; Lenka Gahurova; Tomáš Mašek; Andrea Hauserova; David Potěšil; Denisa Jansova; Andrej Susor; Zbyněk Zdráhal; Anna Ajduk; Martin Pospíšek; Alexander W Bruce
Journal:  Commun Biol       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.